DekaBank Deutsche Girozentrale’s Inhibrx, Inc. Common Stock INBX Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-26,400	Closed	-$928K	–	1489
2024 Q2	$928K	Hold	26,400	–	–	﹤0.01%	893
2024 Q1	$918K	Hold	26,400	–	–	﹤0.01%	894
2023 Q4	$916K	Hold	26,400	–	–	﹤0.01%	919
2023 Q3	$472K	Hold	26,400	–	–	﹤0.01%	1025
2023 Q2	$674K	Hold	26,400	–	–	﹤0.01%	962
2023 Q1	$479K	Hold	26,400	–	–	﹤0.01%	1019
2022 Q4	$625K	Hold	26,400	–	–	﹤0.01%	987
2022 Q3	$452K	Hold	26,400	–	–	﹤0.01%	1063
2022 Q2	$309K	Hold	26,400	–	–	﹤0.01%	1117
2022 Q1	$590K	Buy	26,400 +2,400	+10%	+$61.3K	﹤0.01%	1034
2021 Q4	$1.06M	Buy	+24,000	New	+$960K	﹤0.01%	924

DekaBank Deutsche Girozentrale's INBX Position: Q3 2024 in Review

DekaBank Deutsche Girozentrale sold out of Inhibrx, Inc. Common Stock (INBX) in Q3 2024, closing a stake of 26,400 shares — an estimated $928K sold.

DekaBank Deutsche Girozentrale first reported a position in INBX in Q4 2021 and held it in 11 quarters. The position peaked at $1.06M in Q4 2021. 0 funds tracked by Wall St. Rank hold INBX as of Q3 2024.

DekaBank Deutsche Girozentrale reported no remaining Inhibrx, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 26,400 Inhibrx, Inc. Common Stock shares in Q3 2024, an estimated $928K.
DekaBank Deutsche Girozentrale first reported a position in Inhibrx, Inc. Common Stock in Q4 2021 and held it in 11 quarters.
DekaBank Deutsche Girozentrale's Inhibrx, Inc. Common Stock position peaked at $1.06M in Q4 2021.
0 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q3 2024.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2024, filed 24 Oct 2024.